Overview

Outpatient Treatment of Gram Positive Wound Infections in the Diabetic Foot: A Pharmaco-economic Comparison of Daptomycin vs. Vancomycin Based Regimens

Status:
Terminated

Trial end date:
2012-08-01

Target enrollment:

Participant gender:

Summary

The purpose of the study is to evaluate the overall burden to the participant (economic, quality of life, patients satisfaction and freedom from side effects) when treating Gram positive infections of the foot in diabetic adults with daptomycin versus vancomycin.

Phase:

Phase 4

Details

Lead Sponsor:

Clinical Alliance for Research & Education - Infectious Diseases, LLC.

Collaborator:

Cubist Pharmaceuticals LLC

Treatments:

Daptomycin
Vancomycin